P Cash & equivalents
Cash & equivalents at Everpure rose to $855M in fiscal 2026, the highest in the 5 years reported, from $724M in 2025.
Cash and cash equivalents at year end, as filed.
SOURCE: us-gaap:CashAndCashEquivalentsAtCarryingValue · EDGAR CompanyFacts · CIK 1474432 · EDGAR ↗ · FY2022–FY2026 · ANNUAL
FY2026$855M
FY2025 $724M
HIGH$855M FY2026
LOW$466M FY2022
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Cash & equivalents | Change |
|---|---|---|
| FY2026 | $855M | +$131M |
| FY2025 | $724M | +$21M |
| FY2024 | $702M | +$122M |
| FY2023 | $581M | +$115M |
| FY2022 | $466M | — |
More SAME DATA, OTHER VIEWS
Cash & equivalents across coverage → · P company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.